[114] randomized subjects to semaglutide or placebo to observe the change of liver fat from baseline to week 48, and found that semaglutide significantly reduced hepatic steatosis, improved liver enzymes and metabolic parameters, and had a positive effect on the diagnosis and treatment of NAFLD compared with placebo
Morning Dosing: Some patients prefer taking the medication in the morning
Noctor G, Mhamdi A, Chaouch S, Han Y, Neukermans J, Marquez-Garcia B, Queval G, Foyer CH
Regular alcohol consumption burdens the liver, depleting its natural glutathione stores and impeding detoxification
The most frequently reported AEs were gastrointestinal disorders (19%, 50% and 27% of subjects in the fed, fasting and reference groups, respectively) and headache (15%, 38% and 35%)